Structural Formula Of Dactinomycin (Dac00 0002 01)
Dactinomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dactinomycin (NDC 71288-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel – Dactinomycin For Injection, Usp 500 Mcg Vial Label (Dac00 0002 02)
This is a description of a medication called Dactinomycin (NDC71288-129-02) for injection, which contains 500mcg per vial. It is to be used for the preparation of intravenous solutions only and is a cytotoxic agent, meaning it is potentially harmful. It is manufactured by Meitheal Pharmaceuticals in Chicago, USA and is labeled for prescription use only.*
Principal Display Panel – Dactinomycin For Injection, Usp 500 Mcg Carton (Dac00 0002 03)
This is a medical label for Dactinomycin. The drug is supplied in single-dose vials and contains danger and caution warnings. It contains 500mg of Dactinomycin, an inactive ingredient froswiciny 20mg, and sterile water for injection to reconstitute the drug. The dosage information for USP injection is included in the packaging. The label instructs to store the drug at a temperature between 20°C to 25°C, protect it from light and humidity and discard unused portions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
